Pharmacogenetics of Doxazosin for Cocaine Dependence
Completed · Phase 2 · Has a placebo group
Conditions studied: Cocaine Dependence
In brief
Doxazosin, an alpha 1-adrenergic receptor antagonist, may play an important role in cocaine addiction in humans. This study will evaluate to what extent the prospective screening for catecholamine related polymorphisms for alpha 1 NE receptor/transporter, COMT and DBH as main targets predict the treatment efficacy of doxazosin for cocaine-using behavior.
Key facts
- Study ID
- NCT01145183
- Run by
- Baylor College of Medicine
- People needed
- 96
- Starts
- 2010-03-01
- Expected to finish
- 2015-09-01
- Last updated by the study team
- 2019-07-22
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Baylor College of Medicine — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.